Supreme Court dismisses plea against Ranbaxy
The Supreme Court today dismissed a PIL seeking a probe against Ranbaxy Laboratories Ltd for allegedly manufacturing and selling substandard […]
The Supreme Court today dismissed a PIL seeking a probe against Ranbaxy Laboratories Ltd for allegedly manufacturing and selling substandard […]
Top selling blood pressure drugs and antibiotics could become a lot cheaper as the government plans to notify price caps […]
Despite weak market conditions, the domestic pharmaceutical market reported growth of 6.8 per cent at Rs 6,370 crore for the […]
Zydus Wellness, owner of brands such as Ever Yuth, Sugar Free and Nutralite, has planned to acquire more brands or […]
While intravenous iron is critical for maintaining the health of many dialysis patients, administering large doses over a short period […]
Some more bad news for Ranbaxy. The European Commission has fined the India-based drug-maker, along with eight other firms, on […]
A frontline tuberculosis (TB) drug – kills dormant persister bacteria and plays a critical role in shortening TB therapy. PZA […]
Asian Healthcare Fund (AHF), a private equity firm floated by Dabur Group chairman Anand Burman and former Dabur Pharma CEO […]
Global drugmakers said on Wednesday they would cooperate with an independent review to address concerns of a potential link between […]
Apollo Pharmacy, the country’s largest branded drug retail network with over 1,500 outlets, has temporarily suspended sale of medicines manufactured […]
The Indian Medical Association (IMA), that represents medical practitioners, has asked the Drug Controller General of India (DCGI), to investigate […]
Wockhardt Ltd., maker of insulin and hepatitis vaccines, will not win new drug approvals this year for about half the […]
With an aim to boost pharmaceutical exports to the European Union, the government today said it has issued new guidelines […]